
Global Intracranial Aneurysm Market Report and Forecast 2024-2032
Description
Global Intracranial Aneurysm Market Report and Forecast 2024-2032
Global Intracranial Aneurysm Market Report and Forecast 2024-2032
The global intracranial aneurysm market size was valued at USD 1.2 billion in 2023. It is expected to grow at a CAGR of 8.80% during the forecast period of 2024-2032, driven by rising number of intracranial aneurysms globally. The market is experiencing robust growth and is expected to reach USD 2.6 billion by 2032.
Global Intracranial Aneurysm Market Analysis
The global intracranial aneurysm market is a critical segment within the healthcare and medical device industries, focusing on the diagnosis, management, and treatment of intracranial aneurysms - bulges in blood vessels in the brain that can leak or burst, leading to hemorrhagic stroke, brain damage, or death. This market analysis provides an overview of the current state, driving factors, challenges, and future prospects of the intracranial aneurysm market.
Global Intracranial Aneurysm Market Overview
The market for intracranial aneurysm treatment and management has seen significant growth due to the rising prevalence of the condition, attributed to factors such as hypertension, smoking, genetic predispositions, and aging populations. Advancements in medical imaging technologies have also improved the detection rates of asymptomatic aneurysms, contributing to market growth. The market encompasses a range of products including surgical clips, coils, flow diverters, and stent systems, as well as emerging endovascular techniques that offer less invasive alternatives to traditional surgical approaches.
Key Drivers
Several key drivers are propelling the growth of the intracranial aneurysm market:
- Increased Prevalence: The rising number of intracranial aneurysm cases globally due to lifestyle factors and better diagnostic capabilities.
- Technological Advancements: Innovations in endovascular treatments and surgical equipment have enhanced treatment efficacy and safety.
- Aging Population: Older age groups are at a higher risk for aneurysms, and the growing demographic of elderly individuals worldwide boosts the potential patient base.
- Awareness and Screening: Improved awareness about the condition and advancements in non-invasive screening techniques have led to early detection and treatment.
However, the market faces several challenges:
- High Treatment Costs: Advanced treatments, especially endovascular procedures, can be expensive, limiting accessibility for patients in lower-income regions.
- Risks and Complications: Despite advancements, treatments can carry risks of complications, influencing decision-making by patients and healthcare providers.
- Regulatory Hurdles: Stringent regulatory standards for the approval of new devices and treatments can delay market entry and increase development costs.
Global Intracranial Aneurysm Market Outlook
The intracranial aneurysm market is expected to continue growing, driven by ongoing research and development efforts aimed at enhancing treatment safety, efficacy, and accessibility. The future market growth will likely be supported by:
- Innovative Treatment Modalities: Continued innovation in device design and treatment techniques, including personalized medicine approaches.
- Expansion in Emerging Markets: Increased healthcare investment and infrastructure improvements in developing countries.
- Collaboration and M&A Activities: Strategic collaborations and mergers & acquisitions among key players to expand product offerings and geographic presence.
Global Intracranial Aneurysm Market Trends
The global intracranial aneurysm market is witnessing several key trends that are shaping its growth trajectory and influencing treatment paradigms. These trends reflect advancements in medical technologies, shifts in patient and healthcare provider preferences, and broader demographic changes. Understanding these trends is crucial for stakeholders aiming to navigate the market effectively.
- Minimally Invasive Treatments
- Technological Innovations
- Personalized and Precision Medicine
- Global Health Demographics
- Regulatory and Reimbursement Landscape
- Rising Awareness and Early Detection
The global intracranial aneurysm market is undergoing significant transformations, influenced by technological advancements, demographic shifts, and evolving clinical practices. Stakeholders in the market must adapt to these trends to leverage growth opportunities and address the challenges posed by an increasingly dynamic and competitive landscape.
Global Intracranial Aneurysm Market Segmentation
Market Breakup by Treatment Type
- Surgical Clipping
- Endovascular Coiling
- Flow Diverters
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Intracranial Aneurysm Market Competitive Landscape
The competitive landscape in the medical device sector is highly dynamic, with major players such as Medtronic, Stryker, Shanghai MicroPort Medical (Group) Co., Ltd., B. Braun SE, Terumo Corporation, Delta Surgical, Integra LifeSciences Corporation, Mizuho Medical Co. Ltd, evonos GmbH & Co. KG, and RAUMEDIC AG among others. These companies are known for their innovative products and global reach. The competition is intense, with each company striving to enhance its product portfolio, expand its market presence, and drive technological advancements to meet the evolving needs of the healthcare industry.
Key Questions Answered in the Report
- How is the global intracranial aneurysm market performing now and how is it expected to perform in the future?
- What factors are contributing to the growth of the intracranial aneurysm treatment and management market?
- What are the key drivers and challenges in the market?
- How is the shift towards minimally invasive procedures impacting the treatment of intracranial aneurysms?
- How is the aging global population affecting the intracranial aneurysm market?
- How is the global intracranial aneurysm market segmented by treatment type, and what drives its growth?
- How is the global intracranial aneurysm market segmented by end users, and what trends are influencing its growth?
- Who are the major players in the medical device sector, and how do they influence the competitive landscape?
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global intracranial aneurysm market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the global intracranial aneurysm market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global intracranial aneurysm industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Intracranial Aneurysm Market Overview
- 3.1 Global Intracranial Aneurysm Market Historical Value (2017-2023)
- 3.2 Global Intracranial Aneurysm Market Forecast Value (2024-2032)
- 4 Global Intracranial Aneurysm Market Landscape*
- 4.1 Global Intracranial Aneurysm Market: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Intracranial Aneurysm Market: Product Landscape
- 4.2.1 Analysis by Treatment Type
- 4.2.2 Analysis by Technology
- 5 Global Intracranial Aneurysm Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Intracranial Aneurysm Market Segmentation (2017-2032)
- 6.1 Global Intracranial Aneurysm Market (2017-2032) by Treatment Type
- 6.1.1 Market Overview
- 6.1.2 Surgical Clipping
- 6.1.3 Endovascular Coiling
- 6.1.4 Flow Diverters
- 6.1.5 Others
- 6.2 Global Intracranial Aneurysm Market (2017-2032) by End User
- 6.2.1 Market Overview
- 6.2.2 Hospitals
- 6.2.3 Ambulatory Surgical Centers
- 6.2.4 Others
- 6.3 Global Intracranial Aneurysm Market (2017-2032) by Region
- 6.3.1 Market Overview
- 6.3.2 North America
- 6.3.3 Europe
- 6.3.4 Asia Pacific
- 6.3.5 Latin America
- 6.3.6 Middle East and Africa
- 7 North America Intracranial Aneurysm Market (2017-2032)
- 7.1 North America Intracranial Aneurysm Market (2017-2032) by Treatment Type
- 7.1.1 Market Overview
- 7.1.2 Surgical Clipping
- 7.1.3 Endovascular Coiling
- 7.1.4 Flow Diverters
- 7.1.5 Others
- 7.2 North America Intracranial Aneurysm Market (2017-2032) by Country
- 7.2.1 United States of America
- 7.2.2 Canada
- 8 Europe Intracranial Aneurysm Market (2017-2032)
- 8.1 Europe Intracranial Aneurysm Market (2017-2032) by Treatment Type
- 8.1.1 Market Overview
- 8.1.2 Surgical Clipping
- 8.1.3 Endovascular Coiling
- 8.1.4 Flow Diverters
- 8.1.5 Others
- 8.2 Europe Intracranial Aneurysm Market (2017-2032) by Country
- 8.2.1 United Kingdom
- 8.2.2 Germany
- 8.2.3 France
- 8.2.4 Italy
- 8.2.5 Others
- 9 Asia Pacific Intracranial Aneurysm Market (2017-2032)
- 9.1 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Treatment Type
- 9.1.1 Market Overview
- 9.1.2 Surgical Clipping
- 9.1.3 Endovascular Coiling
- 9.1.4 Flow Diverters
- 9.1.5 Others
- 9.2 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Country
- 9.2.1 China
- 9.2.2 Japan
- 9.2.3 India
- 9.2.4 ASEAN
- 9.2.5 Australia
- 9.2.6 Others
- 10 Latin America Intracranial Aneurysm Market (2017-2032)
- 10.1 Latin America Intracranial Aneurysm Market (2017-2032) by Treatment Type
- 10.1.1 Market Overview
- 10.1.2 Surgical Clipping
- 10.1.3 Endovascular Coiling
- 10.1.4 Flow Diverters
- 10.1.5 Others
- 10.2 Latin America Intracranial Aneurysm Market (2017-2032) by Country
- 10.2.1 Brazil
- 10.2.2 Argentina
- 10.2.3 Mexico
- 10.2.4 Others
- 11 Middle East and Africa Intracranial Aneurysm Market (2017-2032)
- 11.1 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Treatment Type
- 11.1.1 Market Overview
- 11.1.2 Surgical Clipping
- 11.1.3 Endovascular Coiling
- 11.1.4 Flow Diverters
- 11.1.5 Others
- 11.2 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Country
- 11.2.1 Saudi Arabia
- 11.2.2 United Arab Emirates
- 11.2.3 Nigeria
- 11.2.4 South Africa
- 11.2.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Medtronic
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Stryker
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Shanghai MicroPort Medical (Group) Co., Ltd.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 B. Braun SE
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Terumo Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Delta Surgical
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Integra LifeSciences Corporation
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Mizuho Medical Co. Ltd
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 evonos GmbH & Co. KG
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 RAUMEDIC AG
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- List not exhaustive
- 18 Global Intracranial Aneurysm Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.